A Study of DC05F01 in Chinese Patients With Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

This study is testing a new drug called DC05F01 in Chinese patients with advanced cancers — including ovarian cancer, small cell lung cancer, and other solid tumors — that have stopped responding to standard treatments. **You may be eligible if...** - You are 18 years old or older - You have advanced ovarian, fallopian tube, or primary peritoneal cancer that progressed during or within 6 months of platinum chemotherapy - OR you have limited-stage small cell lung cancer that did not progress after at least 4 cycles of platinum-based chemotherapy and radiation - OR you have another advanced solid tumor that has failed standard treatments - You are in good enough health to participate (ECOG performance status 0–1) - You have had previous debulking (tumor-removing) surgery for ovarian cancer **You may NOT be eligible if...** - You have an active serious infection, severe liver or kidney disease, or uncontrolled heart conditions - You are not willing to follow the study requirements or cannot sign consent Talk to your doctor to see if this trial is right for you.